You are here
Effectiveness of GSK's malaria vaccine dwindles in 7 years
THE world's first malaria vaccine, developed by GlaxoSmithKline (GSK), provides some protection after three doses but its effect dwindles to almost nothing after seven years, scientists said on Wednesday.
Publishing a long-term study of the vaccine - called RTS,S or
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org